(Q35109294)

6 August 2017

title

MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides (English)

1 reference

6 August 2017

11

Xiaoyuan Chen

1 reference

6 August 2017

1

Orit Jacobson

1 reference

6 August 2017

9

Dale O Kiesewetter

1 reference

6 August 2017

3

Gang Niu

1 reference

6 August 2017

4

Ido D Weiss

1 reference

6 August 2017

8

Yongjun Yan

1 reference

6 August 2017

5

Lawrence P Szajek

1 reference

6 August 2017

Lei Zhu

2

1 reference

6 August 2017

Ying Ma

series ordinal

6

1 reference

6 August 2017

Xilin Sun

series ordinal

7

1 reference

6 August 2017

Shuang Liu

series ordinal

10

1 reference

6 August 2017

publication date

1 December 2011

1 reference

Molecular Imaging and Biology

6 August 2017

published in

1 reference

6 August 2017

volume

13

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1224-1233

1 reference

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Standardized methods for the production of high specific-activity zirconium-89.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Imaging of integrins as biomarkers for tumor angiogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Multimodality imaging of tumor integrin alphavbeta3 expression

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

The role of integrins in tumor angiogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Angiogenesis in glioma: molecular mechanisms and roadblocks to translation.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Angiogenesis in cancer and other diseases

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Mechanisms of angiogenesis and arteriogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Requirement of vascular integrin alpha v beta 3 for angiogenesis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide

9 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0458-Y

microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Role of alphavbeta3 integrin receptors in breast tumor.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3137711

Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161690

12 December 2020

inferred from PubMed ID database lookup

Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161690

12 December 2020

inferred from PubMed ID database lookup

Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21161690

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11307-010-0458-Y

1 reference

release_hshevgfsmjaevmjqptlwpkz47m

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hshevgfsmjaevmjqptlwpkz47m

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3137711

1 reference

6 August 2017

1 reference